These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37088138)

  • 1. Detecting Low-Variant Allele Frequency Mosaic Pathogenic Variants of NF1, TSC2, and AKT3 Genes from Blood in Patients with Neurodevelopmental Disorders.
    Kim SH; Kwon SS; Park MR; Lee HA; Kim JH; Cha J; Kim S; Baek ST; Kim SH; Lee JS; Kim HD; Choi JR; Lee ST; Kang HC
    J Mol Diagn; 2023 Aug; 25(8):583-591. PubMed ID: 37088138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
    Chang F; Liu L; Fang E; Zhang G; Chen T; Cao K; Li Y; Li MM
    J Mol Diagn; 2017 Jul; 19(4):613-624. PubMed ID: 28502725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of TSC1/TSC2 mosaic variants in patients with cardiac rhabdomyoma and tuberous sclerosis complex by hybrid-capture next-generation sequencing.
    Wang S; Sun H; Wang J; Gu X; Han L; Wu Y; Yan H; Han L; Zhang H; He Y
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1802. PubMed ID: 34480426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.
    Pirozzi F; Berkseth M; Shear R; Gonzalez L; Timms AE; Sulc J; Pao E; Oyama N; Forzano F; Conti V; Guerrini R; Doherty ES; Saitta SC; Lockwood CM; Pritchard CC; Dobyns WB; Novotny E; Wright JNN; Saneto RP; Friedman S; Hauptman J; Ojemann J; Kapur RP; Mirzaa GM
    Brain; 2022 Apr; 145(3):925-938. PubMed ID: 35355055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosaic pathogenic variants in AKT3 cause capillary malformation and undergrowth.
    Bolli A; Nriagu B; Britt AD; Toole AD; Treat J; Srinivasan A; Sheppard SE
    Am J Med Genet A; 2023 May; 191(5):1442-1446. PubMed ID: 36695285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parental mosaicism in de novo neurodevelopmental diseases.
    Shu L; Zhang Q; Tian Q; Yang S; Peng X; Mao X; Yang L; Du J; Wang H
    Am J Med Genet A; 2021 Jul; 185(7):2119-2125. PubMed ID: 33851778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encephalocraniocutaneous lipomatosis phenotype associated with mosaic biallelic pathogenic variants in the
    Smeijers S; Brems H; Verhaeghe A; van Paesschen W; van Loon J; Van der Auweraer S; Sciot R; Thal DR; Lagae L; Legius E; Theys T
    J Med Genet; 2024 Aug; 61(9):904-907. PubMed ID: 38825366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders.
    Stosser MB; Lindy AS; Butler E; Retterer K; Piccirillo-Stosser CM; Richard G; McKnight DA
    Genet Med; 2018 Apr; 20(4):403-410. PubMed ID: 28837158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
    Akgumus G; Chang F; Li MM
    J Mol Diagn; 2017 Jul; 19(4):487-497. PubMed ID: 28502730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients.
    Sala Frigerio C; Lau P; Troakes C; Deramecourt V; Gele P; Van Loo P; Voet T; De Strooper B
    Alzheimers Dement; 2015 Nov; 11(11):1265-76. PubMed ID: 25937274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mosaicism of common pathogenic MECP2 variants identified in two males with a clinical diagnosis of Rett syndrome.
    Cooley Coleman JA; Fee T; Bend R; Louie R; Annese F; Stallworth J; Worthington J; Buchanan CB; Everman DB; Skinner S; Friez MJ; Jones JR; Spellicy CJ
    Am J Med Genet A; 2022 Oct; 188(10):2988-2998. PubMed ID: 35924478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals.
    Truty R; Rojahn S; Ouyang K; Kautzer C; Kennemer M; Pineda-Alvarez D; Johnson B; Stafford A; Basel-Salmon L; Saitta S; Slavotinek A; Chandrasekharappa SC; Suarez CJ; Burnett L; Nussbaum RL; Aradhya S
    Am J Hum Genet; 2023 Apr; 110(4):551-564. PubMed ID: 36933558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum and tissue distribution of RB1 pathogenic alleles in mosaic retinoblastoma patients.
    Zhang Y; Wei WB; Zhao J; Xu X; Wang F
    Ophthalmic Genet; 2022 Dec; 43(6):795-805. PubMed ID: 35938543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting genomic mosaicism in "de novo" genetic epilepsy by amplicon-based deep sequencing.
    Chen J; Chen Y; Yang Y; Niu X; Zhang J; Zeng Q; Liu A; Xu X; Yang X; Li S; Yang X; Wang Y; Zhang Y
    J Hum Genet; 2023 Feb; 68(2):73-80. PubMed ID: 36482122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and Quantification of Mosaic Mutations in Disease Genes by Next-Generation Sequencing.
    Qin L; Wang J; Tian X; Yu H; Truong C; Mitchell JJ; Wierenga KJ; Craigen WJ; Zhang VW; Wong LC
    J Mol Diagn; 2016 May; 18(3):446-453. PubMed ID: 26944031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted deep sequencing of DNA from multiple tissue types improves the diagnostic rate and reveals a highly diverse phenotype of mosaic neurofibromatosis type 2.
    Teranishi Y; Miyawaki S; Hongo H; Dofuku S; Okano A; Takayanagi S; Ota T; Yoshimura J; Qu W; Mitsui J; Nakatomi H; Morishita S; Tsuji S; Saito N
    J Med Genet; 2021 Oct; 58(10):701-711. PubMed ID: 33067351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission Risk.
    Chen JL; Miller DT; Schmidt LS; Malkin D; Korf BR; Eng C; Kwiatkowski DJ; Giannikou K
    Annu Rev Genomics Hum Genet; 2022 Aug; 23():331-361. PubMed ID: 36044908
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chen Y; Yang X; Chen J; Yang X; Yang Y; Liu A; Zhang X; Wu W; Sun D; Yang Z; Jiang Y; Zhang Y
    Front Neurol; 2022; 13():1041509. PubMed ID: 36408521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of parental mosaicism rates in neurodevelopmental disorders caused by apparent de novo pathogenic variants using deep sequencing.
    Lecoquierre F; Cassinari K; Drouot N; May A; Fourneaux S; Charbonnier F; Derambure C; Coutant S; Saugier-Veber P; Hoischen A; Charbonnier C; Nicolas G
    Sci Rep; 2024 Mar; 14(1):5289. PubMed ID: 38438430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Value of Parental Testing by Next-Generation Sequencing Includes the Detection of Germline Mosaicism.
    Brewer CJ; Gillespie M; Fierro J; Scaringe WA; Li JM; Lee CY; Yen HY; Gao H; Strom SP
    J Mol Diagn; 2020 May; 22(5):670-678. PubMed ID: 32092540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.